Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Long-Term Debt Repayments (2020 - 2024)

MedWellAI (MWAI) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $50000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $50000.0 in Q2 2024 year-over-year; TTM through Sep 2024 was $125000.0, a 150.0% increase, with the full-year FY2024 number at $125000.0, up 150.0% from a year prior.
  • Long-Term Debt Repayments was $50000.0 for Q2 2024 at MedWellAI, up from $25000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $50000.0 in Q1 2023 to a low of -$31537.0 in Q2 2021.
  • A 4-year average of $17111.7 and a median of $17184.0 in 2020 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 28.24% in 2021; the steepest drop was 90.35% in 2021.
  • MedWellAI's Long-Term Debt Repayments stood at $17184.0 in 2020, then plummeted by 90.35% to $1659.0 in 2021, then soared by 2913.86% to $50000.0 in 2023, then changed by 0.0% to $50000.0 in 2024.
  • Per Business Quant, the three most recent readings for MWAI's Long-Term Debt Repayments are $50000.0 (Q2 2024), $25000.0 (Q1 2024), and $50000.0 (Q4 2023).